← Back to Search

Intervention Group for Well-being (MBTA Trial)

N/A
Waitlist Available
Led By Dawne S Vogt, PhD BA
Research Sponsored by VA Office of Research and Development
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up measured at t1 (baseline) and t2 (three-month follow-up) for the intervention group and active control group; challenges reported are from baseline (t1) and if they were were taking action to address these challenges are data from three-month follow-up
Awards & highlights
No Placebo-Only Group

Summary

This trial tests a new program called Measurement-Based Transition Assistance (MBTA) that helps recently discharged Veterans by giving them personalized advice on where they might need support, like in health or finding a job. The goal is to encourage Veterans to seek help early and prevent long-term problems.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~measured at t1 (baseline) and t2 (three-month follow-up) for the intervention group and active control group; challenges reported are from baseline (t1) and if they were were taking action to address these challenges are data from three-month follow-up
This trial's timeline: 3 weeks for screening, Varies for treatment, and measured at t1 (baseline) and t2 (three-month follow-up) for the intervention group and active control group; challenges reported are from baseline (t1) and if they were were taking action to address these challenges are data from three-month follow-up for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Number of Participants Assessed for the Feasibility of Study Procedures
Satisfaction With MBTA Tool
Secondary study objectives
Attitudes Toward Seeking Professional Psychological Help-Short Form
Stages Algorithm
Support-Seeking Actions to Improve Well-Being
+2 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Intervention GroupExperimental Treatment1 Intervention
MBTA, MBTA satisfaction measures, and other assessment measures at T1 (baseline); MBTA and other assessment measures at T2 (three month follow-up)
Group II: Active Control GroupActive Control1 Intervention
assessment measures only at T1 (baseline); MBTA, MBTA satisfaction measures, and other assessment measures at T2 (three month follow-up)
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Measurement-Based Transition Assistance (MBTA)
2022
N/A
~50

Find a Location

Who is running the clinical trial?

VA Office of Research and DevelopmentLead Sponsor
1,664 Previous Clinical Trials
3,765,551 Total Patients Enrolled
1 Trials studying Well-being
81 Patients Enrolled for Well-being
Dawne S Vogt, PhD BAPrincipal InvestigatorVA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA
1 Previous Clinical Trials
250 Total Patients Enrolled
~15 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top